Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03031106
Recruitment Status : Unknown
Verified March 2018 by Mia Sommer, Aalborg University Hospital. Recruitment status was: Recruiting
The aim of this study is to adjust and test an existing internet-based tool for collecting patient-reported outcome measures and to use the internet-based tool in an multidisciplinary follow-up of patients treated for malignant hematological diseases. The patient-reported outcome measurements will be used in describing the patients' health-related quality of life (HRQoL) and to investigate whether the HRQol will increase due to participation in multidisciplinary follow-up.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients treated with chemotherapy for primary hematological disease and patients followed in a Wait & Watch regimen
patients diagnosed with malignant hematological disease; Morbus Hodgkin and B- and T-cell disease
patients followed before or after 1. line treatment
patients in stable phase > 6 months after 1. line treatment
the patients participation in the study must be assessed and decided by the doctor responsible for the patient's course of treatment
Health conditions which demands close medical monitoring
conditions which compromise the ability to understand the study and submit informed consent (ex.: dementia and severe mental illness / disability)
lack of capability to fill out electronic questionnaires